
Sign up to save your podcasts
Or
In the fast-paced realm of pharmaceuticals, where innovation can mean the difference between life and death, the integration of artificial intelligence (AI) is reshaping the landscape of drug discovery and development. Mati Gill, CEO at AION Labs, stands at the forefront of this revolution, pioneering the use of AI to tackle the challenges inherent in the pharma industry.
4.5
22 ratings
In the fast-paced realm of pharmaceuticals, where innovation can mean the difference between life and death, the integration of artificial intelligence (AI) is reshaping the landscape of drug discovery and development. Mati Gill, CEO at AION Labs, stands at the forefront of this revolution, pioneering the use of AI to tackle the challenges inherent in the pharma industry.
22,072 Listeners
43,483 Listeners
111,864 Listeners
56,221 Listeners
9 Listeners
5,397 Listeners
9,189 Listeners
417 Listeners
147 Listeners
8,721 Listeners
9 Listeners
3 Listeners